Pacific Shuanglin Bio pharmacy Co Ltd Cash Flow Conversion Efficiency
Pacific Shuanglin Bio pharmacy Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥70.28 Million ≈ $10.28 Million USD) by net assets (CN¥8.03 Billion ≈ $1.17 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Pacific Shuanglin Bio pharmacy Co Ltd (1998–2025)
Cash flow conversion efficiency of Pacific Shuanglin Bio pharmacy Co Ltd from 1998 to 2025. This chart illustrates how Pacific Shuanglin Bio pharmacy Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Pacific Shuanglin Bio pharmacy Co Ltd (000403) stock price for real-time trading data and today's change.
Pacific Shuanglin Bio pharmacy Co Ltd Cash Flow Conversion Ratio Explained
Pacific Shuanglin Bio pharmacy Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Pacific Shuanglin Bio pharmacy Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pacific Shuanglin Bio pharmacy Co Ltd ranked by their cash flow conversion efficiency. Also see 000403 stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Azenta Inc
NASDAQ:AZTA
|
0.002x |
|
Shenzhen Edadoc Technology Co. Ltd. A
SHE:301366
|
N/A |
|
Godawari Power And Ispat limited
NSE:GPIL
|
0.076x |
|
Keel Infrastructure Corp.
NASDAQ:KEEL
|
-0.161x |
|
Huapont Life Sciences Co Ltd
SHE:002004
|
0.037x |
|
Siglent Technologies Co Ltd
SHG:688112
|
0.023x |
|
Lotus Pharmaceutical Co Ltd
TW:1795
|
0.029x |
|
WIN Semiconductors
TWO:3105
|
-0.020x |
Annual Cash Flow Conversion Efficiency for Pacific Shuanglin Bio pharmacy Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Pacific Shuanglin Bio pharmacy Co Ltd from 1998 to 2025. Review free cash flow generation of Pacific Shuanglin Bio pharmacy Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥8.08 Billion ≈ $1.18 Billion |
CN¥-215.99 Million ≈ $-31.61 Million |
-0.027x | -165.76% |
| 2024-12-31 | CN¥7.92 Billion ≈ $1.16 Billion |
CN¥321.79 Million ≈ $47.09 Million |
0.041x | -55.58% |
| 2023-12-31 | CN¥7.42 Billion ≈ $1.09 Billion |
CN¥679.01 Million ≈ $99.36 Million |
0.091x | +19.74% |
| 2022-12-31 | CN¥6.86 Billion ≈ $1.00 Billion |
CN¥524.22 Million ≈ $76.71 Million |
0.076x | +18.43% |
| 2021-12-31 | CN¥6.33 Billion ≈ $925.95 Million |
CN¥408.22 Million ≈ $59.74 Million |
0.065x | -67.99% |
| 2020-12-31 | CN¥966.91 Million ≈ $141.49 Million |
CN¥194.84 Million ≈ $28.51 Million |
0.202x | -15.36% |
| 2019-12-31 | CN¥801.60 Million ≈ $117.30 Million |
CN¥190.84 Million ≈ $27.93 Million |
0.238x | +26.45% |
| 2018-12-31 | CN¥619.48 Million ≈ $90.65 Million |
CN¥116.63 Million ≈ $17.07 Million |
0.188x | +393.01% |
| 2017-12-31 | CN¥558.88 Million ≈ $81.78 Million |
CN¥-35.91 Million ≈ $-5.26 Million |
-0.064x | -156.24% |
| 2016-12-31 | CN¥546.91 Million ≈ $80.03 Million |
CN¥62.49 Million ≈ $9.14 Million |
0.114x | -14.61% |
| 2015-12-31 | CN¥525.49 Million ≈ $76.90 Million |
CN¥70.31 Million ≈ $10.29 Million |
0.134x | -20.34% |
| 2014-12-31 | CN¥458.65 Million ≈ $67.11 Million |
CN¥77.04 Million ≈ $11.27 Million |
0.168x | -35.09% |
| 2013-12-31 | CN¥351.68 Million ≈ $51.46 Million |
CN¥91.01 Million ≈ $13.32 Million |
0.259x | -39.60% |
| 2012-12-31 | CN¥287.68 Million ≈ $42.10 Million |
CN¥123.24 Million ≈ $18.03 Million |
0.428x | -6.92% |
| 2011-12-31 | CN¥282.74 Million ≈ $41.37 Million |
CN¥130.14 Million ≈ $19.04 Million |
0.460x | +1176.66% |
| 2010-12-31 | CN¥274.00 Million ≈ $40.09 Million |
CN¥9.88 Million ≈ $1.45 Million |
0.036x | -95.56% |
| 2009-12-31 | CN¥137.64 Million ≈ $20.14 Million |
CN¥111.86 Million ≈ $16.37 Million |
0.813x | +92.34% |
| 2008-12-31 | CN¥177.26 Million ≈ $25.94 Million |
CN¥74.90 Million ≈ $10.96 Million |
0.423x | -95.59% |
| 2007-12-31 | CN¥9.92 Million ≈ $1.45 Million |
CN¥95.03 Million ≈ $13.91 Million |
9.578x | +2397.05% |
| 2006-12-31 | CN¥-27.16 Million ≈ $-3.97 Million |
CN¥-10.42 Million ≈ $-1.52 Million |
0.384x | -12.05% |
| 2005-12-31 | CN¥112.49 Million ≈ $16.46 Million |
CN¥49.06 Million ≈ $7.18 Million |
0.436x | +299.35% |
| 2004-12-31 | CN¥602.14 Million ≈ $88.11 Million |
CN¥-131.73 Million ≈ $-19.28 Million |
-0.219x | -271.64% |
| 2003-12-31 | CN¥840.33 Million ≈ $122.97 Million |
CN¥-49.47 Million ≈ $-7.24 Million |
-0.059x | -128.81% |
| 2002-12-31 | CN¥779.03 Million ≈ $114.00 Million |
CN¥159.18 Million ≈ $23.29 Million |
0.204x | +26.30% |
| 2001-12-31 | CN¥687.82 Million ≈ $100.65 Million |
CN¥111.28 Million ≈ $16.28 Million |
0.162x | +254.33% |
| 2000-12-31 | CN¥599.28 Million ≈ $87.69 Million |
CN¥27.36 Million ≈ $4.00 Million |
0.046x | +195.34% |
| 1999-12-31 | CN¥481.83 Million ≈ $70.51 Million |
CN¥-23.08 Million ≈ $-3.38 Million |
-0.048x | -326.45% |
| 1998-12-31 | CN¥235.63 Million ≈ $34.48 Million |
CN¥-2.65 Million ≈ $-387.22K |
-0.011x | -- |
About Pacific Shuanglin Bio pharmacy Co Ltd
Pacific Shuanglin Bio-pharmacy Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of blood products in China and internationally. The company offers human serum albumin, human immunoglobulin (PH4), human immunoglobulin, hepatitis B human immunoglobulin, tetanus immunoglobulin, rabies immunoglobulin, human coagulation factor VIII, human fibrinogen… Read more